Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: Insights into the cardiorenal syndrome

Biomarkers

Volumn 16, Issue 4, 2011, Pages 302-310

  Lassus, J P E ^a   Harjola, V P ^b   Peuhkurinen, K ^b   Sund, R ^c   Mebazaa, A ^d   Siirila Waris K ^a   Miettinen, K ^b   Punnonen, K R ^b   Melin, J ^e   Pulkki, K ^d   Nieminen, M S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c National Institute for Health and Welfare   (Finland)

^d HÔPITAL LARIBOISIÈRE   (France)

^e Central Hospital   (Finland)

Author keywords

Cardiovascular disease; growth factors cytokines inflammatory mediators; renal disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIORENAL SYNDROME; CARDIOVASCULAR RISK; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART STRESS; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT;

BIOLOGICAL MARKERS; CYSTATIN C; HEART FAILURE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY DISEASES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957470026     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.555822     Document Type: Article

References (30)

1. Anker SD, von Haehling S. (2004). Inflammatory mediators in chronic heart failure: an overview. Heart 90:464-470. (Pubitemid 38406929)
2. Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L. (1999). Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376-382. (Pubitemid 29066497)
3. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH. (2001). Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16:1189-1197. (Pubitemid 32547374)
4. Bozkurt B, Mann DL, Deswal A. (2010). Biomarkers of inflammation in heart failure. Heart Fail Rev 15:331-341.
5. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. (2008). Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 111:S4-S9.
6. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G. (2008). Cytokines and acute heart failure. Crit Care Med 36:S9-S16.
7. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P. (1995). Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892.
8. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. (2008). Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 118:625-631.
9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305.
10. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J; ADHERE Scientific Advisory Committee and Investigators. (2007). High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422-430. (Pubitemid 47179911)
11. Hilfiker-Kleiner D, Landmesser U, Drexler H. (2006). Molecular mechanisms in heart failure: focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol 48 (Suppl. 1):A56-A66. (Pubitemid 44648642)
12. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG. (2007). Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71:239-244. (Pubitemid 46160924)
13. Lassus JP, Nieminen MS, Peuhkurinen K, Pulkki K, Siirilä-Waris K, Sund R, Harjola VP; FINN-AKVA study group. (2010). Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 31:2791-2798.
14. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. (2006). Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254. (Pubitemid 46768608)
15. Lommi J, Pulkki K, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M. (1997). Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 18:1620-1625. (Pubitemid 27412418)
16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. (2007). Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.
17. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K; ESC Committe for Practice Guideline (CPG). (2005). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart j 26:384-416. (Pubitemid 40283098)
18. Parissis JT, Farmakis D, Nikolaou M, Birmpa D, Bistola V, Paraskevaidis I, Ikonomidis I, Gaitani S, Venetsanou K, Filippatos G, Kremastinos DT. (2009). Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study. Eur J Heart Fail 11:967-972.
19. Petretta M, Condorelli GL, Spinelli L, Scopacasa F, de Caterina M, Leosco D, Vicario ML, Bonaduce D. (2000). Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J 140:E28.
20. Puhakka M, Magga J, Hietakorpi S, Penttilä I, Uusimaa P, Risteli J, Peuhkurinen K. (2003). Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail 9:325-332. (Pubitemid 37048026)
21. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD. (2000). Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060-3067.
22. Roberts MA, Hare DL, Ratnaike S, Ierino FL. (2006). Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 48:341-360. (Pubitemid 44262433)
23. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. (2008). Cardiorenal syndrome. J Am Coll Cardiol 52:1527-1539.
24. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P; Acute Dialysis Quality Initiative (ADQI) consensus group. (2010). Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31:703-711.
25. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (2003). Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169. (Pubitemid 37337595)
26. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. (2003). Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92. (Pubitemid 36070938)
27. Siirilä-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP; FINN-AKVA Study Group. (2006). Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27:3011-3017. (Pubitemid 44950446)
28. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. (2006). Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47:1987-1996.
29. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M. (2005). IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67:1216-1233. (Pubitemid 40463099)
30. Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T. (2005). Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100:415-420.